Skip to main content
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Aug 16;21(10):1841–1847. doi: 10.1158/1055-9965.EPI-12-0560

Table 1.

Demographic and tumor characteristics of lung cancer patients diagnosed during 1990–2003, ACTUR.

Characteristic Small Cell Lung Cancer Adenocarcinoma Squamous Cell Carcinoma Large Cell Carcinoma
White n=1,710 Black n=124 P-value^ White n=3,443 Black n=433 P-value^ White n=2,467 Black n=274 P-value^ White n=1,534 Black n=196 P-value^
Age (years)* No. of patients (%) No. of patients (%) No. of patients (%) 43
 20–44 30 (1.7) 7 (5.7) 142 (4.1) 35 (8.1) 34 (1.4) 7 (2.5) 55 (3.6) 17 (8.7)
 45–54 205 (12.0) 18 (14.5) 399 (11.6) 95 (21.9) 198 (8.0) 35 (12.8) 194 (12.6) 38 (19.4)
 55–64 673 (39.4) 53 (42.7) 1,346 (39.1) 180 (41.6) 896 (36.3) 135 (49.3) 560 (36.5) 76 (38.8)
 65–74 573 (33.5) 42(33.9) 1,153 (33.5) 94 (21.7) 965 (39.1) 80 (29.2) 531 (34.6) 51 (26.0)
 ≥75 229 (13.4) 4 (3.2) <0.01 403 (11.7) 29 (6.7) <0.01 374 (15.2) 17 (6.2) <0.01 194 (12.7) 14 (7.1) <0.01
Sex*
 Men 1,058 (61.9) 73 (58.9) 2,103 (61.1) 297 (68.6) 1,880 (76.2) 203 (74.1) 1,055 (68.8) 155 (79.1)
 Women 652 (38.1) 51 (41.1) 0.51 1,340 (38.9) 136 (31.4) <0.01 587 (23.8) 71 (25.9) 0.44 479 (31.2) 41 (20.9) <0.01
Active Duty*
 Yes 26 (1.5) 7 (5.6) 92 (2.7) 27 (6.2) 26 (1.1) 8 (2.9) 43 (2.8) 13 (6.6)
 No 1,684 (98.5) 117 (94.4) <0.01 3,351 (97.3) 406 (93.8) <0.01 2,441 (98.9) 266 (97.1) 0.01 1,491 (97.2) 183 (93.4) <0.01
Tumor Stage*
 Localized 242 (14.2) 15 (12.1) 1,191 (34.6) 141 (32.6) 840 (34.1) 84 (30.7) 338 (22.0) 35 (17.9)
 Regional 455 (26.6) 41 (33.1) 957 (27.8) 119 (27.5) 931 (37.7) 105 (38.3) 449 (29.3) 62 (31.6)
 Distant 893 (52.2) 60 (48.4) 1,151 (33.4) 159 (36.7) 573 (23.2) 76 (27.7) 629 (41.0) 85 (43.4)
 Unknown 120 (7.0) 8 (6.4) 0.47 144 (4.2) 14 (3.2) 0.47 123 (5.0) 9 (3.3) 0.22 118 (7.7) 14 (7.1) 0.56
Tumor Grade*
 I 6 (0.3) 0 (0.0) 384 (11.1) 48 (11.1) 114 (4.6) 18 (6.6) 11 (0.7) 1 (0.5)
 II 22 (1.3) 2 (1.6) 9.5 (26.3) 97 (22.4) 838 (34.0) 85 (31.0) 38 (2.5) 5 (2.5)
 III 172 (10.1) 18 (14.5) 1,310 (38.1) 177 (40.9) 931 (37.7) 91 (33.2) 694 (45.2) 89 (45.4)
 IV 586 (34.3) 40 (32.3) 23 (0.7) 4 (0.9) 12 (0.5) 1 (0.4) 228 (14.9) 15 (7.7)
 Unknown 924 (54.0) 64 (51.6) 0.56 821 (23.8) 107 (24.7) 0.47 572 (23.2) 79 (28.8) 0.12 563 (36.7) 86 (43.9) 0.06
Surgery
 Yes 171 (10.0) 8 (6.5) 1,832 (53.2) 216 (49.6) 1,057 (42.8) 106 (38.7) 449 (29.3) 55 (28.1)
 No 1,531 (89.5) 115 (92.7) 1,601 (46.5) 215 (49.9) 1,405 (57.0) 168 (61.3) 1,077 (70.2) 141 (71.9)
 Unknown 8 (0.5) 1 (0.8) 0.39 10 (0.3) 2 (0.5) 0.33 5 (0.2) 0 (0.0) 0.30 8 (0.5) 0 (0.0) 0.55
Radiation
 Yes 755 (44.2) 77 (62.1) 1,333 (38.7) 223 (39.5) 1,241 (50.3) 145 (52.9) 829 (54.0) 112 (57.2)
 No 883 (51.6) 44 (35.5) 1,984 (57.6) 304 (55.0) 1,121 (45.4) 118 (43.1) 602 (39.3) 71 (36.2)
 Unknown 72 (4.2) 3 (2.4) <0.01 126 (3.7) 25 (5.5) 0.13 105 (4.3) 11 (4.0) 0.71 103 (6.7) 13 (6.6) 0.70
Chemotherapy
 Yes 1,362 (79.7) 100 (80.7) 805 (23.4) 116 (26.8) 555 (22.5) 66 (24.1) 425 (27.7) 68 (34.7)
 No 293 (17.1) 19 (15.3) 2,524 (73.3) 290 (67.0) 1,825 (74.0) 199 (72.6) 1,028 (67.0) 120 (61.2)
 Unknown 55 (3.2) 5 (4.0) 0.79 114 (3.3) 27 (6.2) <0.01 87 (3.5) 9 (3.3) 0.66 81 (5.3) 8 (4.1) 0.11
Recurrence
 Yes 338 (19.8) 32 (25.8) 600 (17.4) 92 (21.3) 385 (15.6) 40 (14.6) 219 (14.3) 33 (16.8)
 No 1,372 (80.2) 136 (74.2) 0.11 2,843 (82.6) 341 (78.7) 0.05 2,082 (84.4) 234 (85.4) 0.66 1,315 (85.7) 163 (83.2) 0.34
*

At the time of diagnosis;

^

Chi-square test.